Pain· 2016Q1· Clinical trial
Dorsal root ganglion stimulation yielded higher treatment success rate for complex regional pain syndrome and causalgia at 3 and 12 months: a randomized comparative trial
- 609citations
- Q1SCImago
- 2016year
Short summary
Dorsal root ganglion (DRG) stimulation achieved a significantly higher treatment success rate (81.2%) compared to spinal cord stimulation (SCS) (55.7%) at 3 months in patients with lower extremity complex regional pain syndrome or causalgia.
AI-generated from the title and abstract; the full text is not read.
Key points
- DRG stimulation achieved 81.2% treatment success (≥50% pain relief) vs. 55.7% for SCS at 3 months (P < 0.001).
- No difference in device-related or serious adverse events between DRG and SCS groups.
- DRG stimulation showed greater improvements in quality of life and psychological well-being.
- DRG stimulation provided more targeted therapy with less postural variation in paresthesia and reduced extraneous stimulation.
AI-generated from the title and abstract; the full text is not read.
Abstract
Animal and human studies indicate that electrical stimulation of dorsal root ganglion (DRG) neurons may modulate neuropathic pain signals. ACCURATE, a pivotal, prospective, multicenter, randomized comparative effectiveness trial, was conducted in 152 subjects diagnosed with complex regional pain syndrome or causalgia in the lower extremities. Subjects received neurostimulation of the DRG or dorsal column (spinal cord stimulation, SCS). The primary end point was a composite of safety and efficacy at 3 months, and subjects were assessed through 12 months for long-term outcomes and adverse events. The predefined primary composite end point of treatment success was met for subjects with a permanent implant who reported 50% or greater decrease in visual analog scale score from preimplant baseline and who did not report any stimulation-related neurological deficits. No subjects reported stimulation-related neurological deficits. The percentage of subjects receiving ≥50% pain relief and treatment success was greater in the DRG arm (81.2%) than in the SCS arm (55.7%, P < 0.001) at 3 months. Device-related and serious adverse events were not different between the 2 groups. Dorsal root ganglion stimulation also demonstrated greater improvements in quality of life and psychological disposition. Finally, subjects using DRG stimulation reported less postural variation in paresthesia (P < 0.001) and reduced extraneous stimulation in nonpainful areas (P = 0.014), indicating DRG stimulation provided more targeted therapy to painful parts of the lower extremities. As the largest prospective, randomized comparative effectiveness trial to date, the results show that DRG stimulation provided a higher rate of treatment success with less postural variation in paresthesia intensity compared to SCS.
The authors' abstract, as published at the source. Pain, 2016 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Anesthesiology and Pain Medicine
Anesthesiology and Pain MedicineMedicine